Provided by Tiger Trade Technology Pte. Ltd.

Evolent Health

4.50
-0.1000-2.17%
Post-market: 4.500.00000.00%19:30 EDT
Volume:2.53M
Turnover:11.24M
Market Cap:508.77M
PE:-0.99
High:4.54
Open:4.51
Low:4.31
Close:4.60
52wk High:10.08
52wk Low:2.10
Shares:113.06M
Float Shares:94.15M
Volume Ratio:1.03
T/O Rate:2.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.5419
EPS(LYR):-5.0732
ROE:-66.97%
ROA:-0.78%
PB:1.33
PE(LYR):-0.89

Loading ...

Evolent Health, Inc. Expected to Post a Loss of 2 Cents a Share - Earnings Preview

Reuters
·
Aug 04

Evolent Health price target lowered to $5 from $8 at TD Cowen

TIPRANKS
·
Jul 28

Evolent Health Inc : TD Cowen Cuts Target Price to $5 from $8

THOMSON REUTERS
·
Jul 28

Evolent Health Down over 14%, on Pace for Largest Percent Decrease Since November 2025

Dow Jones
·
Jul 24

Evolent Health Cut to Neutral from Buy by Citigroup

Dow Jones
·
Jul 23

Citigroup Downgrades Evolent Health to Neutral From Buy, Adjusts Price Target to $6.75 From $5.50

MT Newswires Live
·
Jul 23

Evolent Health Inc : Citigroup Cuts to Neutral from Buy; Raises Target Price to $6.75 from $5.5

THOMSON REUTERS
·
Jul 23

Evolent Health is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Jul 21

Evolent Health price target raised to $7 from $6 at Canaccord

TIPRANKS
·
Jul 21

BTIG Remains a Buy on Evolent Health (EVH)

TIPRANKS
·
Jul 16

Evolent Health (EVH) Receives a Hold from RBC Capital

TIPRANKS
·
Jul 09

Evolent Health to Report Q2 2026 Results, Host Conference Call

Reuters
·
Jul 09

HON, EVH, OC, GLOB, MKSI Trending With Analysts

TIPRANKS
·
Jul 04

Evolent Health Cut to Hold from Buy by Truist Securities

Dow Jones
·
Jun 30

Evolent Health Inc : Truist Securities Cuts to Hold from Buy

THOMSON REUTERS
·
Jun 30

Truist Downgrades Evolent Health to Hold From Buy, Keeps $7 Price Target, Cites Recent Share Price Strength, Medicaid Headwind

MT Newswires Live
·
Jun 30

U.S. Research Roundup- Comcast, Honeywell Aerospace, Qualys

Reuters
·
Jun 30

Evolent Health Is Maintained at Buy by Truist Securities

Dow Jones
·
Jun 12

Truist Raises Price Target on Evolent Health to $7 From $6, Keeps Buy Rating

MT Newswires Live
·
Jun 12

Evolent Health Shareholders Approve Proposals at 2026 Meeting

TIPRANKS
·
Jun 05